ClinicalTrialsFinder
RecruitingNCT06676254

Role of HbA1c in Predicting Adverse Pregnancy Outcomes

Role of HbA1c in Predicting Adverse Pregnancy Outcomes Among Gestational Diabetes Mellitus Women: a Retrospective Study

Sponsor

National University of Malaysia

Enrollment

195 participants

Start Date

Jun 27, 2024

Study Type

OBSERVATIONAL

Conditions

Gestational Diabetes

Summary

This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.

Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with gestational diabetes. The study is currently recruiting participants at 1 location. People eligible for this study include women.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Department of Obstetrics & Gynaecology, Hospital Canselor Tuanku Muhriz

Cheras, Kuala Lumpur, Malaysia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06676254

Related Trials

Continuous Glucose Monitoring for Women With Gestational Diabetes

NCT0631035616 locations

Early Gestational Diabetes Mellitus

NCT0445191510 locations

Growth Hormone Resistance of Beta-cells A

NCT065714871 location

Community Health Worker-Led Postpartum Diabetes Screening

NCT062094111 location

Cardiometabolic Disease and Substrate Metabolism

NCT075657271 location